Addressing the Impact

WORKPLACE EPIDEMIC

Addressing the Impact


ADDRESSING THE IMPACT

vanguard_drug_divider


According to the Drug Enforcement Agency (DEA), the “New Psychoactive Substance” (NPS) market is a $2,000,000,000 emerging industry that is changing the face of drug abuse in the US.  New Psychoactive Substances are produced by many of the 160,000 chemical manufacturers in China and sold here in the US labeled as “Spice” or “Bath Salts”.  The user experiences are very similar to those associated with traditional drugs of abuse but the collateral damage associated with NPS abuse is far more devastating because of a lack of controls on the products and because they evade detection on today’s standard drug tests. The lack of controls has led to higher incidence of overdose deaths and the increase in undetected drug abuse manifests itself in higher on the job accidents which trigger liability insurance claims which in turn increase the costs of doing business.  According to Leigh Branham, author of “Six Truths about Employee Turnover”, employers should expect a 25-200% increase in annual compensation costs associated with replacing injured employees. An opioid abuser versus non-abuser more than triples healthcare costs for employers.  Outside of workplace expense, the general costs ascribed to downtime and loss of productivity are estimated to be in excess of $336 billion dollars. With over 280 monitored analytes, our proprietary method delivers the most precise, efficient and effective drug testing solutions found in today’s forensic drug testing market. We work with our clients and prospects alike to evaluate and establish workplace drug policies to identify high-risk individuals ahead of employment. Our broad-spectrum mass spectrometric testing solution is highly sensitive and provides a comprehensive, accurate and fast definitive test result; much more so than the “rapid” tests included on most standard drug tests. Loss of production, withdrawal symptoms, workplace accidents, tardiness and an inability to focus are all key indicators that an employee is abusing drugs or alcohol. These symptoms, among many more, are directly impacting healthcare costs and employer liability claims, workers compensation and short-term disability claims

Why Test with VLS?

  • Deter employees from abusing alcohol and drugs
  • Prevent hiring individuals who use illegal drugs
  • Be able to identify early and appropriately refer employees who have drug and/ or alcohol problems
  • Provide a safe workplace for employees
  • Protect the general public and instill customer confidence that employees are working safely
  • Comply with State laws or Federal regulations
  • Benefit from Workers’ Compensation Premium Discount Programs

 

Loss of production, withdrawal symptoms, workplace accidents, tardiness, inability to focus are all key indicators that an employee is abusing drugs or alcohol. These symptoms, among many more, are directly impacting healthcare costs and employer liability claims, workers compensations and short-term disability claims.


CONTACT THE VLS TEAM

AND LEARN MORE ABOUT OUR NPS TEST PANEL